Total Synthesis and Comparative Analysis of Orlistat, Valilactone, and a Transposed Orlistat Derivative:  Inhibitors of Fatty Acid Synthase

Gil Ma, Manuel Zancanella, Yatsandra Oyola, Robyn D. Richardson, Jeffrey W. Smith,* and Daniel Romo*;
Department of Chemistry, Texas A&M University, College Station, Texas 77842-3012, and Cell Adhesion and Extra Cellular Matrix Biology, Burnham Institute for Medical Research, Infectious and Inflammatory Disease Center, La Jolla, California 92037
Org. Lett., 2006, 8 (20), pp 4497–4500
DOI: 10.1021/ol061651o
Publication Date (Web): September 2, 2006
Copyright © 2006 American Chemical Society

 Texas A&M University.

,

 Burnham Institute for Medical Research.

,
*

In papers with more than one author, the asterisk indicates the name of the author to whom inquiries about the paper should be addressed.

, romo@mail.chem.tamu.edu, ; , jsmith@burnham.org

Abstract

Abstract Image

Concise syntheses of orlistat (Xenical), a two-carbon transposed orlistat derivative, and valilactone are described that employ the tandem Mukaiyama aldol−lactonization (TMAL) process as a key step. This process allows facile modification of the α-side chain. Versatile strategies for modifying the δ-side chain are described, involving cuprate addition and olefin metathesis. Comparative antagonistic activity of these derivatives toward a recombinant form of the thioesterase domain of fatty acid synthase is reported along with comparative activity-based profiling.

Tools

History

  • Published In Issue September 28, 2006
  • Received July 5, 2006

Recommend & Share

Related Content

Other ACS content by these authors: